tiprankstipranks
Trending News
More News >
Fresenius Medical Care AG & Co. KGaA (DE:FME)
XETRA:FME

Fresenius Medical Care AG & Co. KGaA (FME) Stock Statistics & Valuation Metrics

Compare
12 Followers

Total Valuation

Fresenius Medical Care AG & Co. KGaA has a market cap or net worth of €14.68B. The enterprise value is €24.83B.
Market Cap€14.68B
Enterprise Value€24.83B

Share Statistics

Fresenius Medical Care AG & Co. KGaA has 293,413,450 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding293,413,450
Owned by Insiders
Owned by Institutions<0.01%

Financial Efficiency

Fresenius Medical Care AG & Co. KGaA’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.35%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)3.35%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee172.59K
Profits Per Employee6.61K
Employee Count112,035
Asset Turnover0.58
Inventory Turnover7.05

Valuation Ratios

The current PE Ratio of Fresenius Medical Care AG & Co. KGaA is 24.09. Fresenius Medical Care AG & Co. KGaA’s PEG ratio is 1.60.
PE Ratio24.09
PS Ratio0.00
PB Ratio1.05
Price to Fair Value0.89
Price to FCF7.61
Price to Operating Cash Flow6.23
PEG Ratio1.60

Income Statement

In the last 12 months, Fresenius Medical Care AG & Co. KGaA had revenue of 19.34B and earned 537.91M in profits. Earnings per share was 1.83.
Revenue19.34B
Gross Profit4.76B
Operating Income1.39B
Pretax Income1.06B
Net Income537.91M
EBITDA3.21B
Earnings Per Share (EPS)1.83

Cash Flow

In the last 12 months, operating cash flow was 2.42B and capital expenditures -711.22M, giving a free cash flow of 1.98B billion.
Operating Cash Flow2.42B
Free Cash Flow1.98B
Free Cash Flow per Share6.76

Dividends & Yields

Fresenius Medical Care AG & Co. KGaA pays an annual dividend of €1.44, resulting in a dividend yield of 2.87%
Dividend Per Share€1.44
Dividend Yield2.87%
Payout Ratio44.04%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.78
52-Week Price Change31.88%
50-Day Moving Average46.14
200-Day Moving Average41.89
Relative Strength Index (RSI)58.75
Average Volume (3m)572.86K

Important Dates

Fresenius Medical Care AG & Co. KGaA upcoming earnings date is Aug 5, 2025, TBA Not Confirmed.
Last Earnings DateMay 6, 2025
Next Earnings DateAug 5, 2025
Ex-Dividend DateMay 23, 2025

Financial Position

Fresenius Medical Care AG & Co. KGaA as a current ratio of 1.40, with Debt / Equity ratio of 75.29%
Current Ratio1.40
Quick Ratio1.03
Debt to Market Cap0.53
Net Debt to EBITDA3.07
Interest Coverage Ratio3.42

Taxes

In the past 12 months, Fresenius Medical Care AG & Co. KGaA has paid 316.06M in taxes.
Income Tax316.06M
Effective Tax Rate0.30

Enterprise Valuation

Fresenius Medical Care AG & Co. KGaA EV to EBITDA ratio is 7.11, with an EV/FCF ratio of 13.51.
EV to Sales1.18
EV to EBITDA7.11
EV to Free Cash Flow13.51
EV to Operating Cash Flow9.55

Balance Sheet

Fresenius Medical Care AG & Co. KGaA has €1.49B in cash and marketable securities with €10.82B in debt, giving a net cash position of €9.33B billion.
Cash & Marketable Securities€1.49B
Total Debt€10.82B
Net Cash€9.33B
Net Cash Per Share€31.81
Tangible Book Value Per Share-€2.63

Margins

Gross margin is 24.46%, with operating margin of 7.20%, and net profit margin of 2.78%.
Gross Margin24.46%
Operating Margin7.20%
Pretax Margin5.47%
Net Profit Margin2.78%
EBITDA Margin16.58%
EBIT Margin7.57%

Analyst Forecast

The average price target for Fresenius Medical Care AG & Co. KGaA is €48.64, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target€48.64
Price Target Upside-3.72% Downside
Analyst ConsensusHold
Analyst Count13
Revenue Growth Forecast0.10%
EPS Growth Forecast27.83%

Scores

Smart Score7
AI Score68
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis